Aichi, Japan

Ichiro Mori

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ichiro Mori. Retrieved from https://idiyas.com/inventor/ichiro-mori-v8hnws0c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ichiro Mori: Innovator in Chemical Compounds

Introduction

Ichiro Mori is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of chemical compounds, particularly in the development of derivatives that have potential therapeutic applications. His work focuses on creating innovative solutions to address medical challenges.

Latest Patents

Ichiro Mori holds 1 patent for his invention related to chemical compounds, specifically 3-carboxy quinoline derivatives. These compounds are recognized for their utility as YAK3 inhibitors. The patent details methods for synthesizing these derivatives and outlines their application in treating diseases associated with inappropriate YAK3 activity.

Career Highlights

Mori is affiliated with SmithKline Beecham Corporation, where he applies his expertise in chemical research and development. His work at the company has contributed to advancements in pharmaceutical sciences, particularly in the area of targeted therapies.

Collaborations

Throughout his career, Ichiro Mori has collaborated with esteemed colleagues, including Joelle Lorraine Burgess and James Francis Callahan. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Ichiro Mori's contributions to the field of chemical compounds exemplify the impact of innovative thinking in medicine. His work continues to pave the way for new treatments that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…